Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Killestein

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|May 18, 2006
Anti-myelin antibodies in multiple sclerosis: clinically useful?C H Polman, J Killestein
International MS Journal|August 10, 2007
Cytotoxic immune responses mediated by monoclonal antibodies in MS: incorrectly dismissed as ineffective?J Killestein, C H Polman
Nederlands Tijdschrift Voor Geneeskunde|August 30, 1997
[Therapeutic applications and biomedical effects of cannabinoids; pharmacological starting points]J Killestein, S A Nelemans
Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2005
Cannabinoids in multiple sclerosis: urgent need for long term trialsJ Killestein, B M J Uitdehaag
Lancet (London, England)|August 2, 2005
Effect of rimonabant on weight reduction and cardiovascular riskBw van Oosten, J Killestein, Ch Polman
European Journal of Neurology|November 8, 2011
Natalizumab discontinuation: an increasingly tricky propositionT W West, J Killestein, R J Fox
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 28, 2009
Very late delayed-allergic reaction to natalizumab not associated with neutralizing antibodiesJ Killestein, B Jasperse, M Liedorp, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
Opticospinal multiple sclerosis: a pathogenetically distinct form?M J Eikelenboom, J Killestein, B M Uitdehaag, et al.
International Ophthalmology|January 1, 1996
Outcome of cataract surgery by a general medical doctor at district level, Zimbabwe: a retrospective follow-up studyJ Killestein, M Hillegers, C van der Windt, et al.
Chaos (Woodbury, N.Y.)|December 2, 2020
Early-warning signals for disease activity in patients diagnosed with multiple sclerosis based on keystroke dynamicsJ Twose, G Licitra, H McConchie, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Journal of Neurology, Neurosurgery, and Psychiatry|May 18, 2006
Anti-myelin antibodies in multiple sclerosis: clinically useful?C H Polman, J Killestein
International MS Journal|August 10, 2007
Cytotoxic immune responses mediated by monoclonal antibodies in MS: incorrectly dismissed as ineffective?J Killestein, C H Polman
Nederlands Tijdschrift Voor Geneeskunde|August 30, 1997
[Therapeutic applications and biomedical effects of cannabinoids; pharmacological starting points]J Killestein, S A Nelemans
Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2005
Cannabinoids in multiple sclerosis: urgent need for long term trialsJ Killestein, B M J Uitdehaag
Lancet (London, England)|August 2, 2005
Effect of rimonabant on weight reduction and cardiovascular riskBw van Oosten, J Killestein, Ch Polman
European Journal of Neurology|November 8, 2011
Natalizumab discontinuation: an increasingly tricky propositionT W West, J Killestein, R J Fox
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 28, 2009
Very late delayed-allergic reaction to natalizumab not associated with neutralizing antibodiesJ Killestein, B Jasperse, M Liedorp, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
Opticospinal multiple sclerosis: a pathogenetically distinct form?M J Eikelenboom, J Killestein, B M Uitdehaag, et al.
International Ophthalmology|January 1, 1996
Outcome of cataract surgery by a general medical doctor at district level, Zimbabwe: a retrospective follow-up studyJ Killestein, M Hillegers, C van der Windt, et al.
Chaos (Woodbury, N.Y.)|December 2, 2020
Early-warning signals for disease activity in patients diagnosed with multiple sclerosis based on keystroke dynamicsJ Twose, G Licitra, H McConchie, et al.
Pageof 9